Literature DB >> 16717214

Decreasing incidence of lacunar vs other types of cerebral infarction in a Japanese population.

M Kubo1, Y Kiyohara, T Ninomiya, Y Tanizaki, K Yonemoto, Y Doi, J Hata, Y Oishi, K Shikata, M Iida.   

Abstract

BACKGROUND: There is scant information on secular trends in the incidence and survival of ischemic stroke subtypes.
METHODS: The authors established three cohorts of Hisayama residents age > or =40 years in 1961 (1,618 subjects), 1974 (2,038 subjects), and 1988 (2,637 subjects). They followed up with each cohort for 12 years, comparing the incidence and survival rate of ischemic stroke subtypes. Morphologic examinations by autopsy or brain imaging was performed on most of the ischemic stroke cases in all cohorts.
RESULTS: The age-standardized incidence of lacunar infarction significantly declined by 59% for men and by 28% for women from the first to the second cohort. It continued to decline by 41% for men, but the decline decelerated for women between the second and third cohort. The age-standardized incidence of atherothrombotic infarction tended to decline from the first to the second cohort, whereas it was sustained between the second and third cohort for both sexes. The age-standardized incidence of cardioembolic infarction was unchanged throughout the cohorts. In these cohorts, mean blood pressure levels among hypertensive subjects and the prevalence of current smoker decreased with time, though the prevalence of hypertension remained stable. The 5-year survival rate after lacunar infarction significantly improved among the cohorts, but those of atherothrombotic and cardioembolic infarction did not.
CONCLUSIONS: These data suggest that, in the Japanese population, the incidence of lacunar infarction steadily declined for the last 40 years. The improvement of hypertension control and decreasing prevalence of smoking might be responsible for this trend.

Entities:  

Mesh:

Year:  2006        PMID: 16717214     DOI: 10.1212/01.wnl.0000216132.95207.b4

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

Review 2.  Oral anticoagulants for Asian patients with atrial fibrillation.

Authors:  Ian Sabir; Kaivan Khavandi; Jack Brownrigg; A John Camm
Journal:  Nat Rev Cardiol       Date:  2014-03-11       Impact factor: 32.419

3.  Predictors of lowering SBP to assigned targets at 12 months in the Secondary Prevention of Small Subcortical Strokes study.

Authors:  John W Graves; Carole L White; Jeff M Szychowski; Pablo E Pergola; Oscar R Benavente; Christopher S Coffey; Lindsey N Hornung; Robert G Hart
Journal:  J Hypertens       Date:  2012-06       Impact factor: 4.844

Review 4.  Ischemic stroke subtype classification: an asian viewpoint.

Authors:  Bum Joon Kim; Jong S Kim
Journal:  J Stroke       Date:  2014-01-31       Impact factor: 6.967

5.  Primary aldosteronism in patients with acute stroke: prevalence and diagnosis during initial hospitalization.

Authors:  Yosuke Miyaji; Yuichi Kawabata; Hideto Joki; Shunsuke Seki; Kentaro Mori; Tomoya Kamide; Akira Tamase; Hiroshi Shima; Motohiro Nomura; Yoshihisa Kitamura; Hirotatsu Nakaguchi; Taichi Minami; Tetsuji Tsunoda; Mayuko Sasaki; Masayo Yamada; Fumiaki Tanaka
Journal:  BMC Neurol       Date:  2016-09-17       Impact factor: 2.474

6.  Genetic Predisposition to Ischemic Stroke: A Polygenic Risk Score.

Authors:  Tsuyoshi Hachiya; Yoichiro Kamatani; Atsushi Takahashi; Jun Hata; Ryohei Furukawa; Yuh Shiwa; Taiki Yamaji; Megumi Hara; Kozo Tanno; Hideki Ohmomo; Kanako Ono; Naoyuki Takashima; Koichi Matsuda; Kenji Wakai; Norie Sawada; Motoki Iwasaki; Kazumasa Yamagishi; Tetsuro Ago; Toshiharu Ninomiya; Akimune Fukushima; Atsushi Hozawa; Naoko Minegishi; Mamoru Satoh; Ryujin Endo; Makoto Sasaki; Kiyomi Sakata; Seiichiro Kobayashi; Kuniaki Ogasawara; Motoyuki Nakamura; Jiro Hitomi; Yoshikuni Kita; Keitaro Tanaka; Hiroyasu Iso; Takanari Kitazono; Michiaki Kubo; Hideo Tanaka; Shoichiro Tsugane; Yutaka Kiyohara; Masayuki Yamamoto; Kenji Sobue; Atsushi Shimizu
Journal:  Stroke       Date:  2016-12-29       Impact factor: 7.914

7.  Persistent or permanent atrial fibrillation is associated with severe cardioembolic stroke in patients with non-valvular atrial fibrillation.

Authors:  Joji Hagii; Norifumi Metoki; Shin Saito; Hiroshi Shiroto; Satoko Sasaki; Koki Takahashi; Hiroyasu Hitomi; Yoshiko Baba; Natsumi Yamada; Satoshi Seino; Takaatsu Kamada; Takamitsu Uchizawa; Taigen Nakamura; Minoru Yasujima; Hirofumi Tomita
Journal:  Thromb J       Date:  2021-03-31

8.  Diabetes and hypertension markedly increased the risk of ischemic stroke associated with high serum resistin concentration in a general Japanese population: the Hisayama Study.

Authors:  Haruhiko Osawa; Yasufumi Doi; Hideichi Makino; Toshiharu Ninomiya; Koji Yonemoto; Ryoichi Kawamura; Jun Hata; Yumihiro Tanizaki; Mitsuo Iida; Yutaka Kiyohara
Journal:  Cardiovasc Diabetol       Date:  2009-11-18       Impact factor: 9.951

9.  Adiposity and risk of cardiovascular diseases in Japan: secular trend, individual level associations and causal pathway - implications for the prevention of cardiovascular diseases in societies with rapid economic development.

Authors:  Hiroshi Yatsuya; Kazumasa Yamagishi; Hiroyasu Iso
Journal:  EPMA J       Date:  2011-03-27       Impact factor: 6.543

10.  Human Urinary Kallidinogenase decreases recurrence risk and promotes good recovery.

Authors:  Dong Han; Xin Chen; Dongmei Li; Shuang Liu; Yi Lyu; Juan Feng
Journal:  Brain Behav       Date:  2018-07-20       Impact factor: 2.708

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.